There is an old adage that misery loves company, which could explain exactly why, if it is true, Pfizer (PFE) is attempting what would be a very unlikely tie up with Wyeth (WYE). Other than short-term cost savings and finding a sympathetic ear to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer-Wyeth Merger Looks Unwise
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account